Botanical species · safety record

Cissampelos pareira

The EFSA Compendium of Botanicals holds 15 constituent measurements and 8 adverse-effect records for Cissampelos pareira. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cissampelos pareira L.

15Constituent measurements
8Safety records
9Cited sources
4Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 4 licensed products naming Cissampelos pareira as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Root

What the records describe

Constituents measured

  • Isoquinoline alkaloids5
  • Alkaloids3
  • Calcium oxalate2
  • 1-bebeerine1
  • Hayatine1
  • Pareirubrine a1
  • Pareirubrine b1
  • Tannins1

Plant parts

  • Roots and other underground parts12
  • Leaves10
  • Live plants1

Preparations

  • Solvent extraction16
  • Drying (dehydration)4

Effect types

  • Reproductive8

Target tissues

  • Urogenital8

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsLeavesSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
Calcium oxalateLeavesMicroscopic detectionResolve DOI
Isoquinoline alkaloidsRoots and other underground partsSolvent extractionElement spectroscopyResolve DOI
Isoquinoline alkaloidsRoots and other underground partsSolvent extraction4e-04 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
1-bebeerineRoots and other underground partsSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
AlkaloidsRoots and other underground partsSolvent extraction6.61 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
AlkaloidsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
Calcium oxalateRoots and other underground partsMicroscopic detectionNo resolvable identifier
HayatineRoots and other underground partsNo resolvable identifier
Isoquinoline alkaloidsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
Isoquinoline alkaloidsRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
Isoquinoline alkaloidsLive plantsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
Pareirubrine aRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
Pareirubrine bRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
TanninsRoots and other underground partsSolvent extraction14.78 PercentUnspecifiedNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
ReproductiveUrogenitalLeavesSolvent extractionHouse mouse (as animal)Reproduction toxicityResolve DOI
ReproductiveUrogenitalLeavesSolvent extractionHouse mouse (as animal)Reproduction toxicityResolve DOI
ReproductiveUrogenitalLeavesSolvent extractionHouse mouse (as animal)Reproduction toxicityResolve DOI
ReproductiveUrogenitalLeavesSolvent extractionHouse mouse (as animal)Reproduction toxicityResolve DOI
ReproductiveUrogenitalLeavesDrying (dehydration)House mouse (as animal)Reproduction toxicityNo resolvable identifier
ReproductiveUrogenitalLeavesDrying (dehydration)House mouse (as animal)Reproduction toxicityNo resolvable identifier
ReproductiveUrogenitalLeavesDrying (dehydration)House mouse (as animal)Reproduction toxicityNo resolvable identifier
ReproductiveUrogenitalLeavesDrying (dehydration)House mouse (as animal)Reproduction toxicityNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Ganguly, Mausumi., Borthakur, Mridul Kr., Devi, Nirada., Mahanta, Rita. Antifertility activity of the methanolic leaf extract of Cissampelos pareira in female albino mice . Journal of ethnopharmacology, 2007, vol. 111, no. 3, p. 688-691. DOI
  2. Junaimuang, T., Luangpirom, A., Somsapt, P. Antiepileptic antifertility properties of Cissampelos pareira Linn. leaf gel in male and female mice. International journal of phytomedicine, 2015, vol. 7, no. 1, p. 112-118.
  3. MORITA, H., MATSUMOTO, K., TAKEYA, K., ITOKAWA, H., IITAKA, Y. STRUCTURES AND SOLID-STATE TAUTOMERIC FORMS OF 2 NOVEL ANTILEUKEMIC TROPOLOISOQUINOLINE ALKALOIDS, PAREIRUBRINE-A AND PAREIRUBRINE-B, FROM CISSAMPELOS-PAREIRA . Chemical & pharmaceutical bulletin, 1993, vol. 41, no. 8, p. 1418-1422.
  4. MORITA, H., MATSUMOTO, K., TAKEYA, K., ITOKAWA, H. AZAFLUORANTHENE ALKALOIDS FROM CISSAMPELOS-PAREIRA. Chemical & pharmaceutical bulletin, 1993, vol. 41, no. 7, p. 1307-1308.
  5. Hullatti, K. K., Sharada, M. S. Comparative phytochemical investigation of the sources of ayurvedic drug Patha: A chromatographic fingerprinting analysis . Indian journal of pharmaceutical sciences, 2010, vol. 72, no. 1, p. 39-45.
  6. Sudhakaran, M.V. Histo-morphological, fluorescent and powder microscopic characterization of Cissampelos pareira Linn.. Pharmacognosy journal, 2012, vol. 4, no. 34, p. 57-68. DOI
  7. Mukerji, B., Bhandari, P. R. Cissampelos pareira, source of a new curariform drug. Planta medica, 1959, vol. 7, p. 250-9.
  8. ANWER, F., POPLI, SP., SRIVASTA.RM., KHARE, MP. STUDIES IN MEDICINAL PLANTS .3. PROTOBERBERINE ALKALOIDS FROM ROOTS OF CISSAMPELOS PAREIRA LINN . Experientia, 1968, vol. 24, no. 10, p. 999-&. DOI
  9. MORITA, H., TAKEYA, K., ITOKAWA, H. A NOVEL CONDENSED TROPONE-ISOQUINOLINE ALKALOID, PAREITROPONE, FROM CISSAMPELOS-PAREIRA . Bioorganic & medicinal chemistry letters, 1995, vol. 5, no. 6, p. 597-598. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue